SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $113,000 | – | 320,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |